Cullinan Therapeutics Inc
(CGEM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CGEM | YDES | REPL | ||
| Company | Cullinan Therapeutics Inc | Yd Bio Limited | Replimune Group Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.69 | 10.31 | 7.96 | ||
| High | 12.18 | 10.31 | 8.41 | ||
| Low | 11.40 | 9.81 | 7.87 | ||
| Latest | 11.59 | 9.84 | 7.97 | ||
| Change | -0.10 | +0.03 | -0.01 | ||
| % Change | -0.86% | +0.31% | -0.13% | ||
| Volume | 840,700 | 8,500 | 909,500 | ||
| 20-Day Average Volume | 683,320 | 37,470 | 1,364,965 | ||
| Previous Close | 11.69 | 9.81 | 7.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.99 | 11.40 | 7.46 | ||
| 20-Day Raw Stochastic | 38.26% | 2.92% | 73.17% | ||
| 20-Day Relative Strength | 51.52 | 39.47 | 49.61 | ||
| Weighted Alpha | +31.21 | N/A | +0.11 | ||
| Today's Opinion | 88% Buy | N/A | 8% Buy | ||
| Previous Opinion | 88% Buy | N/A | 24% Buy | ||
| Last Month's Opinion | 100% Buy | N/A | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.23% since 02/06/26 | -12.77% since 02/06/26 | +2.84% since 02/06/26 | ||
| Low | 11.36 on 02/11/26 | 9.76 on 02/12/26 | 7.43 on 02/11/26 | ||
| High | 12.55 on 02/10/26 | 11.80 on 02/09/26 | 8.41 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | +8.01% since 01/13/26 | -16.75% since 01/13/26 | -0.87% since 01/13/26 | ||
| Low | 10.45 on 01/20/26 | 9.76 on 02/12/26 | 6.77 on 01/20/26 | ||
| High | 13.43 on 02/03/26 | 12.50 on 01/23/26 | 8.41 on 02/13/26 | ||
| 3-Month | |||||
| %Chg | +40.15% since 11/13/25 | -2.77% since 11/13/25 | -11.25% since 11/13/25 | ||
| Low | 7.93 on 11/14/25 | 7.90 on 11/25/25 | 6.77 on 01/20/26 | ||
| High | 13.43 on 02/03/26 | 15.72 on 12/08/25 | 11.26 on 12/02/25 | ||
| 6-Month | |||||
| %Chg | +51.70% since 08/13/25 | N/A since 08/29/25 | +56.58% since 08/13/25 | ||
| Low | 5.68 on 10/03/25 | 7.20 on 08/29/25 | 3.12 on 09/22/25 | ||
| High | 13.43 on 02/03/26 | 25.00 on 09/12/25 | 11.26 on 12/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 684,691 | 693,927 | 658,107 | ||
| Shares Outstanding, K | 59,076 | 70,521 | 82,573 | ||
| Annual Sales | 0 | 510,360 | 0 | ||
| Annual Net Income | -167,380,000 | -1,411,559 | -247,300,000 | ||
| Last Quarter Sales | 0 | 186,000 | 0 | ||
| Last Quarter Net Income | -50,610,000 | 1,157,000 | -70,930,000 | ||
| 60-Month Beta | -0.09 | N/A | 0.73 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.77 on 11/06/25 | N/A | -0.90 on 11/06/25 | ||
| Latest Earnings Date | 02/26/26 | N/A | 05/28/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||